Nimodipine, a calcium channel blocker initially manufactured and marketed for the treatment of hypertension, is also used in preventing vasospasm secondary to subarachnoid hemorrhage (a type of cerebral hemorrhage). Nimodipine comes under the brand called Nimotop. The global Nimodipine market is expected to grow at a CAGR of xx% during the forecast period 2021-2027. The […]
